References: Practical information on using antibacterial drugs

  • Bai AD, McKenna S, Wise H, Loeb M, Gill SS. Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants. JAMA Netw Open 2022;5(12):e2247426. https://www.ncbi.nlm.nih.gov/pubmed/36534400
  • Boast A, Curtis N, Gwee A. QUESTION 1: Teething issues: can doxycycline be safely used in young children? Arch Dis Child 2016;101(8):772-4. https://www.ncbi.nlm.nih.gov/pubmed/27312004
  • Bradley JS, Kauffman RE, Balis DA, Duffy CM, Gerbino PG, Maldonado SD, et al. Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin. Pediatrics 2014;134(1):e146-53. https://www.ncbi.nlm.nih.gov/pubmed/24918220
  • Chen YY, Yang SF, Yeh HW, Yeh YT, Huang JY, Tsao SL, et al. Association Between Aortic Aneurysm and Aortic Dissection With Fluoroquinolones Use in Patients With Urinary Tract Infections: A Population-Based Cohort Study. J Am Heart Assoc 2022;11(6):e023267. https://www.ncbi.nlm.nih.gov/pubmed/35229623
  • Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf 2016;15(3):367-82. https://www.ncbi.nlm.nih.gov/pubmed/26680308
  • Elgammal A, Ryan J, Bradley C, Crean A, Bermingham M. The impact of drug palatability on prescribing and dispensing of antibiotic formulations for paediatric patients: a cross-sectional survey of general practitioners and pharmacists. Fam Pract 2023. https://www.ncbi.nlm.nih.gov/pubmed/37410016
  • Fjeld H, Raknes G. [Is combining metronidazole and alcohol really hazardous?]. Tidsskr Nor Laegeforen 2014;134(17):1661-3. https://www.ncbi.nlm.nih.gov/pubmed/25223673
  • Gaillard T, Briolant S, Madamet M, Pradines B. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J 2017;16(1):148. https://www.ncbi.nlm.nih.gov/pubmed/28407772
  • Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002;46(6):1619-28. https://www.ncbi.nlm.nih.gov/pubmed/12019066
  • Hemphill ME, Mollanazar NK, Hsu S. Doxycycline Is Safe for Short-Term Use in Children of All Ages. Skinmed 2019;17(5):322. https://www.ncbi.nlm.nih.gov/pubmed/31782706
  • Lau C, Marriott D, Bui J, Figtree M, Gould M, Chubaty A, et al. LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring. Int J Antimicrob Agents 2023;61(5):106783. https://www.ncbi.nlm.nih.gov/pubmed/36921808
  • Matsui D, Lim R, Tschen T, Rieder MJ. Assessment of the palatability of beta-lactamase-resistant antibiotics in children. Arch Pediatr Adolesc Med 1997;151(6):599-602. https://www.ncbi.nlm.nih.gov/pubmed/9193246
  • Medicines and Healthcare products Regulatory Agency (MHRA). Systemic fusidic acid and interaction with statins. Department of Health and Social Care, editor. UK; 2014. https://www.gov.uk/drug-safety-update/systemic-fusidic-acid-and-interaction-with-statins
  • Melloni C, Cohen-Wolkowiez M, Anand R, Payne EH, Benjamin DK. Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care - Doxycycline. Best Pharmaceuticals for Children Act (BPCA) Clinical Reports. Bethesda (MD); 2017. https://www.ncbi.nlm.nih.gov/pubmed/34928549
  • Mergenhagen KA, Wattengel BA, Skelly MK, Clark CM, Russo TA. Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions. Antimicrob Agents Chemother 2020;64(3). https://www.ncbi.nlm.nih.gov/pubmed/31871085
  • Noel GJ, Bradley JS, Kauffman RE, Duffy CM, Gerbino PG, Arguedas A, et al. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J 2007;26(10):879-91. https://www.ncbi.nlm.nih.gov/pubmed/17901792
  • Poyhonen H, Nurmi M, Peltola V, Alaluusua S, Ruuskanen O, Lahdesmaki T. Dental staining after doxycycline use in children. J Antimicrob Chemother 2017;72(10):2887-90. https://www.ncbi.nlm.nih.gov/pubmed/29091225
  • Remschmidt C, Behnke M, Kola A, Pena Diaz LA, Rohde AM, Gastmeier P, et al. The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study. Antimicrob Resist Infect Control 2017;6:95. https://www.ncbi.nlm.nih.gov/pubmed/28924472
  • Stultz JS, Eiland LS. Doxycycline and Tooth Discoloration in Children: Changing of Recommendations Based on Evidence of Safety. Ann Pharmacother 2019;53(11):1162-6. https://www.ncbi.nlm.nih.gov/pubmed/31280586
  • Thompson EJ, Wu H, Melloni C, Balevic S, Sullivan JE, Laughon M, et al. Population Pharmacokinetics of Doxycycline in Children. Antimicrob Agents Chemother 2019;63(12). https://www.ncbi.nlm.nih.gov/pubmed/31548185
  • Todd SR, Dahlgren FS, Traeger MS, Beltran-Aguilar ED, Marianos DW, Hamilton C, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr 2015;166(5):1246-51. https://www.ncbi.nlm.nih.gov/pubmed/25794784
  • Zou F, Cui Z, Lou S, Ou Y, Zhu C, Shu C, et al. Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database. Front Pharmacol 2024;15:1338902. https://www.ncbi.nlm.nih.gov/pubmed/38434706